ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies

Wang, Lina; Liu, Zejun; He, Shumei; He, Shasha; Wang, Yupeng*南方医科大学; 南阳理工学院; 1
Journal of Materials Chemistry B2021-6-14DOI: 10.1039/d1tb00149c
9被引5阅读
引用收藏
分享

摘要

Pt(ii)-based antitumor drugs (e.g. cisplatin and oxaliplatin) are one of the most successful and frequently used drugs in cancer chemotherapy at present. However, drug resistance and severe side effects are the major problems in the application of platinum drugs. Detoxification of Pt(ii) drugs is one of the most important mechanisms of drug resistance. Herein, a supramolecular Pt(iv) prodrug nano-assembly delivery system is designed and used to encapsulate a gamma-glutamyl transferase (GGT) inhibitor (OU749) (Pt-CD/Dex-Ad@OU nano-assemblies) for the synergistic chemotherapy of cisplatin-resistant cancer. Pt-CD/Dex-Ad@OU nano-assemblies could be efficiently taken up by cisplatin-resistant cancer cells and release a drug in the intracellular reductive environment. The Pt-CD/Dex-Ad@OU nano-assemblies can efficiently suppress the expression of GGT, depleting GSH and augmenting ROS via the reduction of the Pt(iv) prodrug. Thereby, by breaking the redox balance the detoxification and antiapoptosis mechanisms of Pt(ii) drugs can be overcome. Thereafter, the excellent therapeutic efficacy of Pt-CD/Dex-Ad@OU nano-assemblies is validated on a cisplatin-resistant human non-small cell lung cancer (A549/DDP) model. Furthermore, the inhibition of GGT protein is expected to reduce the nephrotoxicity of cisplatin. Collectively, this study provides a promising strategy to break the redox balance for overcoming drug resistance and maximizing the efficacy of platinum-based cancer therapy.

学科与关键词

关键词
MOLECULAR-MECHANISMSDELIVERYTRANSPEPTIDASEGLUTATHIONEPROGRESSIONGENERATION
相关
加载中…
  • Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer
    Wang, Yupeng; Luo, Zhijian; Zhou, Dongfang; Wang, Xuefeng; Chen, Jianjun; Gong, Shipeng; Yu, Zhiqiang*Biomaterials Science, 2021, 9(11): 4110-4119.被引 19
  • Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP
    Liu, Yuan; Wang, Yiru; Guan, Xue; Wu, Qiong; Zhang, Mengjun; Cui, Ping; Wang, Can; Chen, Xiuwei*; Meng, Xianwei*; Ma, Tengchuang*ACS applied materials & interfaces, 2023, 15(22): 26484-26495.被引 1
  • A Cascade Targeted and Mitochondrion-Dysfunctional Nanomedicine Capable of Overcoming Drug Resistance in Hepatocellular Carcinoma
    Yang, Yuanyuan; Mai, Ziyi; Zhang, Yanxin; Yu, Zhiyu; Li, Wenjing; Zhang, Yuxuan; Li, Fangzhou; Timashev, Peter; Luan, Ping; Luo, Dixian*; Liang, Xing-Jie*; Yu, Zhiqiang*ACS Nano, 2023, 17(2): 1275-1286.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Materials Chemistry B
发表日期
2021-06-14
卷期
第 9 卷, 第 22 期
页码
4587-4595
DOI
10.1039/d1tb00149c
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [51903119]; China Postdoctoral Science Foundation [2020M672543]; Hebei Normal University Science and Technology Foundation [L2021B44]

作者

  • W

    Wang, Lina (第一作者)

    hebei normal univ

  • L

    Liu, Zejun

    hebei normal univ

查看全部 5 位作者收起作者
  • H

    He, Shumei

    hebei normal univ

  • H

    He, Shasha

    nanyang technol univ

  • W

    Wang, Yupeng (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417